BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23252446)

  • 1. A retrospective study of propranolol therapy in 109 infants with infantile hemangioma.
    Gan LQ; Ni SL; Tan Q; Wang H
    Pediatr Dermatol; 2013; 30(2):270-2. PubMed ID: 23252446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective study of propranolol therapy in 635 infants with infantile hemangioma.
    Luo Y; Zeng Y; Zhou B; Tang J
    Pediatr Dermatol; 2015; 32(1):151-2. PubMed ID: 24602103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants.
    Erbay A; Sarialioglu F; Malbora B; Yildirim SV; Varan B; Tarcan A; Gülcan H; Demir S; Derbent M; Uslu N; Abbasoğlu A
    Turk J Pediatr; 2010; 52(5):450-6. PubMed ID: 21434528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol for treatment of ulcerated infantile hemangiomas.
    Saint-Jean M; Léauté-Labrèze C; Mazereeuw-Hautier J; Bodak N; Hamel-Teillac D; Kupfer-Bessaguet I; Lacour JP; Naouri M; Vabres P; Hadj-Rabia S; Nguyen JM; Stalder JF; Barbarot S;
    J Am Acad Dermatol; 2011 May; 64(5):827-32. PubMed ID: 21353332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse Drug Reactions Following Propranolol in Infantile Hemangioma.
    Pandey V; Tiwari P; Imran M; Mishra A; Kumar D; Sharma SP
    Indian Pediatr; 2021 Aug; 58(8):753-755. PubMed ID: 34465658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of systemic propranolol treatment on physical growth of patients with infantile hemangiomas.
    Hu L; Zhou B; Huang H; Chang L; Qiu Y; Ma G; Chen H; Jin Y; Xu X; Lin X; Li W
    J Dermatol; 2016 Oct; 43(10):1160-1166. PubMed ID: 26945921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propranolol therapy in 55 infants with infantile hemangioma: dosage, duration, adverse effects, and outcome.
    Schupp CJ; Kleber JB; Günther P; Holland-Cunz S
    Pediatr Dermatol; 2011; 28(6):640-644. PubMed ID: 21995836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Propranolol in infantile hemangiomas].
    Léauté-Labrèze C
    Arch Pediatr; 2015 Apr; 22(4):452-5. PubMed ID: 25753275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol for infantile haemangiomas: single centre experience of 250 cases and proposed therapeutic protocol.
    Solman L; Murabit A; Gnarra M; Harper JI; Syed SB; Glover M
    Arch Dis Child; 2014 Dec; 99(12):1132-6. PubMed ID: 25123404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nadolol for the treatment of infantile hemangioma.
    Villalba-Moreno AM; Cotrina-Luque J; Del Vayo-Benito CA; Flores-Moreno S; Bautista-Paloma FJ
    Am J Health Syst Pharm; 2015 Jan; 72(1):44-6. PubMed ID: 25511837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary results of propranolol treatment for patients with infantile hemangioma.
    Corapcioğlu F; Büyükkapu-Bay S; Binnetoğlu K; Babaoğlu A; Anik Y; Tugay M
    Turk J Pediatr; 2011; 53(2):137-41. PubMed ID: 21853649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful management of airway hemangioma with propranolol.
    Mendiratta V; Varghese B; Chander R; Parakh A; Solanki RS
    Int J Dermatol; 2013 Jun; 52(6):750-2. PubMed ID: 23679882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic corticosteroid is effective and safe treatment for problematic infantile hemangioma.
    Greene AK
    Pediatr Dermatol; 2010; 27(3):322-3. PubMed ID: 20609168
    [No Abstract]   [Full Text] [Related]  

  • 14. An infantile bronchial hemangioma unresponsive to propranolol therapy: case report and literature review.
    Sierpina DI; Chaudhary HM; Walner DL; Aljadeff G; Dubrow IW
    Arch Otolaryngol Head Neck Surg; 2011 May; 137(5):517-21. PubMed ID: 21576565
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.
    Sadykov RR; Podmelle F; Sadykov RA; Kasimova KR; Metellmann HR
    Int J Oral Maxillofac Surg; 2013 Jul; 42(7):863-7. PubMed ID: 23618833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel topical nano-propranolol for treatment of infantile hemangiomas.
    Chen ZG; Zheng JW; Yuan ML; Zhang L; Yuan WE
    Nanomedicine; 2015 Jul; 11(5):1109-15. PubMed ID: 25791814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol treatment for infantile hemangioma: a case series of sixty-two patients.
    Stringari G; Barbato G; Zanzucchi M; Marchesi M; Cerasoli G; Tchana B; Gritti A; Boccaletti V; Lombardi AA; Carano N
    Pediatr Med Chir; 2016 Jun; 38(2):113. PubMed ID: 27345601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperkalemia complicating propranolol treatment of an infantile hemangioma.
    Pavlakovic H; Kietz S; Lauerer P; Zutt M; Lakomek M
    Pediatrics; 2010 Dec; 126(6):e1589-93. PubMed ID: 21115582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infantile haemangioma: clinical and demographic characteristics, experiences in the treatment].
    Csoma ZR; Dalmády S; Ábrahám R; Rózsa T; Rácz K; Kemény L
    Orv Hetil; 2017 Oct; 158(39):1535-1544. PubMed ID: 28942665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic superiority of combined propranolol with short steroids course over propranolol monotherapy in infantile hemangioma.
    Aly MM; Hamza AF; Abdel Kader HM; Saafan HA; Ghazy MS; Ragab IA
    Eur J Pediatr; 2015 Nov; 174(11):1503-9. PubMed ID: 25982338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.